NCT00233064: Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis) |
|
|
| Completed | 4 | 417 | US | Lyophilized Palivizumab, Synagis, Liquid Palivizumab | MedImmune LLC | Chronic Lung Disease | 10/07 | 11/07 | | |
NCT00484393: Tetracaine Compared to Placebo for Reducing Pain With Palivizumab - A Pilot Study |
|
|
| Completed | 4 | 7 | Canada | tetracaine 4% gel, Ametop, Placebo, Aquatain used as placebo to look like tetracaine | Fraser Health | Pain | 04/08 | 04/08 | | |
2007-004105-10: Effect of palivizumab on respiratory syncytial virus-associated burden of disease – a randomized controlled trial |
|
|
| Ongoing | 4 | 452 | Europe | Palivizumab, EU/1/99/117/001 and EU/1/99/117/002, Synagis (MEDI-493, palivizumab), Synagis (MEDI-493, palivizumab) | Wilhelmina Children\'s Hospital | Long term respiratory complaints as a possible consequence of RSV bronchiolitis | | | | |
